Increasing oxygen requirements and disease severity in pregnant individuals with the SARS-CoV-2 Delta variant.
作者信息
Eid Joe, Abdelwahab Mahmoud, Caplan Madeleine, Bilbe Caroline, Hajmurad Sema, Costantine Maged M, Rood Kara M
机构信息
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University, 395 W 12th Ave., Columbus, OH 43210.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University, 395 W 12th Ave., Columbus, OH 43210.
出版信息
Am J Obstet Gynecol MFM. 2022 May;4(3):100612. doi: 10.1016/j.ajogmf.2022.100612. Epub 2022 Mar 10.
Abstract
摘要
相似文献
1
Increasing oxygen requirements and disease severity in pregnant individuals with the SARS-CoV-2 Delta variant.感染新冠病毒德尔塔变异株的孕妇对氧气的需求增加且疾病严重程度加剧。
Am J Obstet Gynecol MFM. 2022 May;4(3):100612. doi: 10.1016/j.ajogmf.2022.100612. Epub 2022 Mar 10.
2
COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance.与德尔塔（B.1.617.2）和奥密克戎（B.1.1.529）变体为主导相关的 COVID-19 病例和妊娠及新生儿阳性病例中的疾病严重程度。
JAMA. 2022 Apr 19;327(15):1500-1502. doi: 10.1001/jama.2022.4356.
3
Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.围产期大量 SARS-CoV-2 阳性妊娠的母婴及新生儿结局：一项单中心前瞻性对照研究。
Eur J Obstet Gynecol Reprod Biol. 2021 Feb;257:11-18. doi: 10.1016/j.ejogrb.2020.11.068. Epub 2020 Dec 1.
4
Lessons learnt in transitioning from universal screening to universal testing of pregnant patients for SARS-CoV-2 at the largest municipal health system in America.在美国最大的市级卫生系统中，从对孕妇进行普遍筛查过渡到对其进行SARS-CoV-2普遍检测过程中的经验教训。
J Perinatol. 2021 May;41(5):1174-1176. doi: 10.1038/s41372-020-00889-4. Epub 2021 Jan 18.
5
Repeat positive severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) testing ≥90 days apart in pregnant women.孕妇严重急性呼吸综合征冠状病毒2（2019冠状病毒病）检测结果呈阳性，且两次检测间隔≥90天。
Am J Obstet Gynecol MFM. 2021 May;3(3):100331. doi: 10.1016/j.ajogmf.2021.100331. Epub 2021 Feb 19.
6
Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France.法国：感染 SARS-CoV-2 德尔塔变异株的孕妇 COVID-19 严重程度增加。
Emerg Infect Dis. 2022 May;28(5):1048-1050. doi: 10.3201/eid2805.212080. Epub 2022 Feb 18.
7
Screening and Testing Pregnant Patients for SARS-CoV-2: First-Wave Experience of a Designated COVID-19 Hospitalization Centre in Montréal.对 SARS-CoV-2 感染孕妇进行筛查和检测：蒙特利尔指定 COVID-19 住院中心的第一波经验。
J Obstet Gynaecol Can. 2021 May;43(5):571-575. doi: 10.1016/j.jogc.2020.11.001. Epub 2020 Nov 5.
8
Clinical characteristics of pregnant women with COVID-19 in Japan: a nationwide questionnaire survey.日本 COVID-19 孕妇的临床特征：一项全国性问卷调查。
BMC Pregnancy Childbirth. 2021 Sep 18;21(1):636. doi: 10.1186/s12884-021-04113-9.
9
Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units.入住分娩单元的孕妇体内的严重急性呼吸综合征冠状病毒2抗体。
Am J Obstet Gynecol. 2021 Jan;224(1):112-114. doi: 10.1016/j.ajog.2020.09.022. Epub 2020 Sep 21.
10
Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India.普遍筛查可识别出印度孕妇中无症状的新冠病毒携带者。
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:503-505. doi: 10.1016/j.ejogrb.2020.09.030. Epub 2020 Sep 23.
引用本文的文献
1
Maternal and Perinatal Outcomes of SARS-CoV-2 and Variants in Pregnancy.孕期感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其变体的孕产妇和围产期结局
Matern Fetal Med. 2023 Mar 27;5(2):104-114. doi: 10.1097/FM9.0000000000000189. eCollection 2023 Apr.
2
Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?SARS-CoV-2 从母亲到胎儿或新生儿的传播：需要了解什么，应该怎么做？
Semin Fetal Neonatal Med. 2023 Feb;28(1):101429. doi: 10.1016/j.siny.2023.101429. Epub 2023 Mar 13.
3
Vaccination options for pregnant women during the Omicron period.奥密克戎流行期间孕妇的疫苗接种选择。
J Reprod Immunol. 2023 Mar;156:103798. doi: 10.1016/j.jri.2023.103798. Epub 2023 Jan 6.
4
Association of Infection with Different SARS-CoV-2 Variants during Pregnancy with Maternal and Perinatal Outcomes: A Systematic Review and Meta-Analysis.感染不同 SARS-CoV-2 变异株与妊娠母婴结局的相关性：系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Nov 29;19(23):15932. doi: 10.3390/ijerph192315932.
5
Severe maternal morbidity and mortality during the COVID-19 pandemic: a cohort study in Rio de Janeiro.新冠疫情期间的严重孕产妇发病和死亡情况：里约热内卢的一项队列研究
IJID Reg. 2023 Mar;6:1-6. doi: 10.1016/j.ijregi.2022.11.004. Epub 2022 Nov 10.
6
Brixia and qSOFA Scores, Coagulation Factors and Blood Values in Spring versus Autumn 2021 Infection in Pregnant Critical COVID-19 Patients: A Preliminary Study.2021年春季与秋季妊娠重症COVID-19患者感染中的Brixia和qSOFA评分、凝血因子及血液值：一项初步研究
Healthcare (Basel). 2022 Jul 29;10(8):1423. doi: 10.3390/healthcare10081423.
7
Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants.接种疫苗的孕妇在不同 SARS-CoV-2 变异株流行期间 COVID-19 严重程度降低。
Am J Reprod Immunol. 2022 Sep;88(3):e13596. doi: 10.1111/aji.13596. Epub 2022 Jul 15.
本文引用的文献
1
Association of the Delta (B.1.617.2) Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) With Pregnancy Outcomes.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的德尔塔（B.1.617.2）变体与妊娠结局的关联。
Obstet Gynecol. 2021 Dec 1;138(6):838-841. doi: 10.1097/AOG.0000000000004595.
2
Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant.与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）德尔塔（B.1.617.2）变异株相关的孕产妇和围产期结局
Obstet Gynecol. 2021 Dec 1;138(6):842-844. doi: 10.1097/AOG.0000000000004607.
3
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).关注的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）变异株的临床和病毒学特征：比较 B.1.1.7（阿尔法）、B.1.351（贝塔）和 B.1.617.2（德尔塔）的回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136. doi: 10.1093/cid/ciab721.
Zotero 插件